<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="HB216__files/filelist.xml">
<title>HB216</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>SMA</o:Author>
  <o:Template>SB.dotm</o:Template>
  <o:LastAuthor>clerk1</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2024-12-23T21:23:00Z</o:LastPrinted>
  <o:Created>2025-01-16T04:00:00Z</o:Created>
  <o:LastSaved>2025-01-16T04:00:00Z</o:LastSaved>
  <o:Pages>26</o:Pages>
  <o:Words>3720</o:Words>
  <o:Characters>21452</o:Characters>
  <o:Company>HB template, revision no. 00004</o:Company>
  <o:Bytes>44351</o:Bytes>
  <o:Lines>532</o:Lines>
  <o:Paragraphs>142</o:Paragraphs>
  <o:CharactersWithSpaces>25247</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:RevisionNumber dt:dt="string">00004</o:RevisionNumber>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=dataStoreItem href="HB216__files/item0001.xml"
target="HB216__files/props002.xml">
<link rel=themeData href="HB216__files/themedata.thmx">
<link rel=colorSchemeMapping href="HB216__files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:View>Print</w:View>
  <w:ActiveWritingStyle Lang="EN-US" VendorID="8" DLLVersion="513" NLCheck="0">1</w:ActiveWritingStyle>
  <w:FormsDesign/>
  <w:AttachedTemplate HRef="\\profile\All\Template\Drafting\SB.dotm"></w:AttachedTemplate>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" LatentStyleCount="376">
  <w:LsdException Locked="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="Mention"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="Hashtag"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="Unresolved Mention"/>
  <w:LsdException Locked="false" Priority="99" SemiHidden="true"
   UnhideWhenUsed="true" Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:AvantGarde;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Century Gothic";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"3 of 9 Barcode";
	panose-1:4 2 114 0 0 0 0 0 0 0;
	mso-font-alt:"Courier New";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:4.5in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Courier;
	text-transform:uppercase;
	mso-font-kerning:0pt;
	font-weight:normal;}
h3
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-bidi-font-family:"Times New Roman";
	font-weight:normal;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Header Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.MsoLineNumber
	{mso-style-unhide:no;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.BEITENACTED, li.BEITENACTED, div.BEITENACTED
	{mso-style-name:"BE IT ENACTED";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.5in;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.ABILLFORANACT, li.ABILLFORANACT, div.ABILLFORANACT
	{mso-style-name:"A BILL FOR AN ACT";
	mso-style-unhide:no;
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.ChamberHeading, li.ChamberHeading, div.ChamberHeading
	{mso-style-name:"Chamber Heading";
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:4.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MeasureNumberHeading, li.MeasureNumberHeading, div.MeasureNumberHeading
	{mso-style-name:"Measure Number Heading";
	mso-style-unhide:no;
	margin:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	tab-stops:4.5in;
	font-size:30.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{mso-style-name:"\(1\)Paragraph";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:decimal 49.5pt left 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{mso-style-name:"\(A\)Subparagraph";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	text-indent:-1.5in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in decimal 92.9pt left 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.iClause, li.iClause, div.iClause
	{mso-style-name:"\(i\)Clause";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	text-indent:-2.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in decimal 128.9pt left 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{mso-style-name:"\(A\)SubparagraphContd";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	text-indent:-1.5in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in decimal 92.9pt left 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{mso-style-name:"\(1\)ParagraphContd";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:decimal 49.5pt left 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.ExtraSig, li.ExtraSig, div.ExtraSig
	{mso-style-name:"Extra Sig";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:243.0pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{mso-style-name:"\#Regular Paragraphs";
	mso-style-unhide:no;
	mso-style-link:"\#Regular Paragraphs Char";
	margin:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MeasureTitle, li.MeasureTitle, div.MeasureTitle
	{mso-style-name:MeasureTitle;
	mso-style-unhide:no;
	mso-style-parent:"Heading 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.5in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	text-transform:uppercase;}
p.ReportTitle, li.ReportTitle, div.ReportTitle
	{mso-style-name:ReportTitle;
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Description, li.Description, div.Description
	{mso-style-name:Description;
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.ConstQuestionParagraph, li.ConstQuestionParagraph, div.ConstQuestionParagraph
	{mso-style-name:"Const\. Question Paragraph";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.5in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Paragraph, li.Paragraph, div.Paragraph
	{mso-style-name:Paragraph;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:decimal 49.7pt left 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Subparagraph, li.Subparagraph, div.Subparagraph
	{mso-style-name:Subparagraph;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	text-indent:-1.5in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in decimal 92.9pt left 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;
	mso-ansi-font-size:12.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";}
p.ResolutionBody, li.ResolutionBody, div.ResolutionBody
	{mso-style-name:"Resolution Body";
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:JA;}
span.BillSectionNumber
	{mso-style-name:"Bill Section Number";
	mso-style-unhide:no;
	mso-ansi-font-size:12.0pt;
	font-family:Courier;
	mso-ascii-font-family:Courier;
	mso-hansi-font-family:Courier;}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{mso-style-name:XNotesHeading;
	mso-style-unhide:no;
	mso-style-parent:"\#Regular Paragraphs";
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.XNotes, li.XNotes, div.XNotes
	{mso-style-name:XNotes;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"\#Regular Paragraphs";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Amend, li.Amend, div.Amend
	{mso-style-name:Amend;
	mso-style-unhide:no;
	margin:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.PCa, li.PCa, div.PCa
	{mso-style-name:"PC\(a\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"\(1\)Paragraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in decimal 49.5pt left 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Misc, li.Misc, div.Misc
	{mso-style-name:"Misc\.";
	mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.Transfer, li.Transfer, div.Transfer
	{mso-style-name:Transfer;
	mso-style-unhide:no;
	mso-style-parent:"Misc\.";
	margin:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.aPenalBlock, li.aPenalBlock, div.aPenalBlock
	{mso-style-name:"\(a\)PenalBlock";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"\(1\)Paragraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.RegularParagraphsChar
	{mso-style-name:"\#Regular Paragraphs Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"\#Regular Paragraphs";
	mso-ansi-font-size:12.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";}
p.Effective, li.Effective, div.Effective
	{mso-style-name:Effective;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"\#Regular Paragraphs";
	margin:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in 1.0in 1.5in 2.0in 2.5in 3.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-font-kerning:0pt;
	mso-ligatures:none;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("HB216__files/header.htm") fs;
	mso-footnote-continuation-separator:url("HB216__files/header.htm") fcs;
	mso-endnote-separator:url("HB216__files/header.htm") es;
	mso-endnote-continuation-separator:url("HB216__files/header.htm") ecs;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:.8in 1.0in 1.3in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-page-numbers:1;
	mso-title-page:yes;
	mso-even-header:url("HB216__files/header.htm") eh1;
	mso-header:url("HB216__files/header.htm") h1;
	mso-even-footer:url("HB216__files/header.htm") ef1;
	mso-footer:url("HB216__files/header.htm") f1;
	mso-first-header:url("HB216__files/header.htm") fh1;
	mso-first-footer:url("HB216__files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 11.0in;
	margin:.8in 1.0in 1.3in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-line-numbers-count-by:1;
	mso-forms-protection:no;
	mso-title-page:yes;
	mso-even-header:url("HB216__files/header.htm") eh1;
	mso-header:url("HB216__files/header.htm") h2;
	mso-even-footer:url("HB216__files/header.htm") ef2;
	mso-footer:url("HB216__files/header.htm") f2;
	mso-first-header:url("HB216__files/header.htm") fh1;
	mso-first-footer:url("HB216__files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 11.0in;
	margin:.8in 1.0in 1.3in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-forms-protection:no;
	mso-title-page:yes;
	mso-even-header:url("HB216__files/header.htm") eh1;
	mso-header:url("HB216__files/header.htm") h2;
	mso-even-footer:url("HB216__files/header.htm") ef2;
	mso-footer:url("HB216__files/header.htm") f3;
	mso-first-header:url("HB216__files/header.htm") fh1;
	mso-first-footer:url("HB216__files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection3
	{page:WordSection3;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="2"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in;word-wrap:break-word'>

<div class=WordSection1>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=649
 style='border-collapse:collapse;mso-table-layout-alt:fixed;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid'>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading>HOUSE OF REPRESENTATIVES</p>
  </td>
  <td width=246 rowspan=4 valign=top style='width:184.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MeasureNumberHeading>H.B. NO.<span style='font-size:11.0pt;
  mso-bidi-font-size:10.0pt'><o:p></o:p></span></p>
  </td>
  <td width=102 valign=top style='width:76.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading>216</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading>THIRTY-THIRD LEGISLATURE, 2025</p>
  </td>
  <td width=102 valign=top style='width:76.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading><o:p>&nbsp;</o:p></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading>STATE OF HAWAII</p>
  </td>
  <td width=102 valign=top style='width:76.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading><o:p>&nbsp;</o:p></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='tab-stops:4.5in'><span style='font-size:11.0pt;
  mso-bidi-font-size:10.0pt;font-family:"Arial",sans-serif;mso-bidi-font-family:
  "Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=102 valign=top style='width:76.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=ChamberHeading><o:p>&nbsp;</o:p></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;height:4.0pt;mso-height-rule:exactly'>
  <td width=102 colspan=3 valign=top style='width:76.3pt;border:none;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:4.0pt;mso-height-rule:exactly'>
  <p class=MsoNormal><span style='font-size:4.0pt;mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;mso-yfti-lastrow:yes;height:2.0pt;mso-height-rule:
  exactly'>
  <td width=102 colspan=3 valign=top style='width:76.3pt;border:none;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .75pt;
  padding:0in 5.4pt 0in 5.4pt;height:2.0pt;mso-height-rule:exactly'>
  <p class=MsoNormal><span style='font-size:2.0pt;mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
  <p class=MsoNormal><span style='font-size:2.0pt;mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

<p class=ABILLFORANACT>A BILL FOR AN ACT</p>

<p class=MsoNormal><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;
font-family:"AvantGarde",sans-serif'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;
font-family:"AvantGarde",sans-serif'><o:p>&nbsp;</o:p></span></p>

<p class=MeasureTitle><span style='mso-bidi-font-family:"Courier New"'>relating
to prescription drugs</span>.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=BEITENACTED>BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

<span class=MsoLineNumber><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:auto;mso-break-type:section-break'>
</span></span>

<div class=WordSection2>

<p class=RegularParagraphs><a name="_Hlk114575812"><span style='mso-bidi-font-family:
"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION 1.<span
style='mso-spacerun:yes'>  </span>The legislature finds that health insurance
plans are increasingly making use of step therapy protocols which require
patients to try one or more prescription drug alternatives before insurance coverage
is provided for the particular prescription drug selected by the patient's
health care provider. <span style='mso-spacerun:yes'> </span>Step therapy
protocols can serve an important role in controlling health care costs when
they are based on well-developed scientific standards and administered in a
flexible manner that considers the individual needs of patients.<span
style='mso-spacerun:yes'>  </span>However, requiring a patient to follow a step
therapy protocol may have adverse and even dangerous consequences for a patient
who may not realize a benefit from taking a required prescription drug
alterative or suffer harm if the step therapy protocol requires use of a drug
that is inappropriate for the patient.</a></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-tab-count:1'>     </span>The legislature further finds that without
uniform statewide policies in place for step therapy protocols, residents of
the State may have varying access to appropriate health care treatment depending
on their particular insurance carrier.<span style='mso-spacerun:yes'>  </span>It
is imperative that step therapy protocols in the State preserve heath care
providers' right to make treatment decisions in the best interest of the
patient.</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>The
legislature finds that it is necessary for the protection of public health and
safety to require health insurers to base step therapy protocols on appropriate
clinical practice guidelines or published peer reviewed data developed by
independent experts with knowledge of the condition or conditions under
consideration.<span style='mso-spacerun:yes'>  </span>To protect the interest
of patients statewide, step therapy protocols should include provisions to
exempt patients for whom step therapy would be inappropriate and should ensure
that patients have access to a fair, transparent, and independent process for
requesting an exception to a step therapy protocol when the patients' physician
deems it to be appropriate.</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span>Accordingly,
t</span>he purpose of this Act is to require all insurers in the State to adopt
minimum standards for the use of step therapy protocols to ensure the fair,
consistent, and transparent provision of prescription drugs to residents of the
State.</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
2.<span style='mso-spacerun:yes'>  </span>Chapter 431, Hawaii Revised Statutes,
is amended by adding a new section to article 10A to be appropriately
designated and to read as follows:</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><b>&quot;</b><b
style='mso-bidi-font-weight:normal'><u>§431:10A-&nbsp;&nbsp;</u><span
style='mso-spacerun:yes'>  </span><u>Step therapy protocol; requirements; exceptions.</u></b><span
style='mso-spacerun:yes'>  </span><u>(a)<span style='mso-spacerun:yes'> 
</span>Clinical review criteria used to establish a step therapy protocol shall
be based on clinical practice guidelines.<span style='mso-spacerun:yes'> 
</span>Clinical practice guidelines shall:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Recommend that the prescription
drugs be taken in the specific sequence required by the step therapy protocol;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(2)</u><span
style='mso-tab-count:1'>  </span></span><u>Be developed and endorsed by a
multidisciplinary panel of experts that manages conflicts of interest among the
members of the writing and review groups by:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Requiring members to disclose any
potential conflict of interests with entities, including insurers, health
plans, and pharmaceutical manufacturers and recuse themselves of voting if they
have a conflict of interest;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Using a methodologist to work with
writing groups to provide objectivity in data analysis and ranking of evidence
through the preparation of evidence tables and facilitating consensus; and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Offering opportunities for public
review and comments;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-tab-count:2'>          </span><u>provided that in the absence of a
panel, peer reviewed publications shall suffice;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Be based on high quality studies,
research, and medical practices;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-tab-count:1'>     </span><u>(4)</u><span style='mso-tab-count:1'>  </span><u>Be
established under an explicit and transparent process that:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Minimizes biases and conflicts of
interest;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Explains the relationship between
treatment options and outcomes;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Rates the quality of the evidence
supporting recommendations; and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Considers relevant patient subgroups
and preferences;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(5)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Be continually updated through a
review of new evidence, research, and newly developed treatments; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(6)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Consider the needs of atypical
patient populations and diagnoses;<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><u>Nothing
in this subsection shall be construed to require an insurer, utilization review
organization, or health care provider to create any new entity to develop
clinical review criteria used for step therapy protocols.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(b)<span
style='mso-spacerun:yes'>  </span>When coverage of a prescription drug for the
treatment of any medical condition is restricted for use by an insurer or
utilization review organization through the use of a step therapy protocol, the
patient and the prescribing practitioner shall have access to request a step
therapy exception through a clear and convenient process which shall be readily
accessible through the insurer or utilization review organization's
website.<span style='mso-spacerun:yes'>  </span>An insurer or utilization
review organization may use its existing medical exceptions or appeal process
to satisfy this requirement; provided that the process complies with the
requirements of this section.<span style='mso-spacerun:yes'>  </span></u></span><span
style='mso-bookmark:_Hlk114575812'><u><span style='mso-bidi-font-family:"Courier New"'>An
insurer or utilization review organization shall upon written request:<o:p></o:p></span></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(1)</u><span
style='mso-tab-count:1'>  </span><u>Provide a</u></span><u>ll written clinical
review criteria relating to a particular condition or disease or a step therapy
exception determination;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(2)</u><span
style='mso-tab-count:1'>  </span><u>Display t</u></span><u>he requested clinical
review criteria and other clinical information on its website; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(3)</u><span
style='mso-tab-count:1'>  </span><u>D</u></span><u>istribute </u></span><span
style='mso-bookmark:_Hlk114575812'><u><span style='mso-bidi-font-family:"Courier New"'>t</span>he
requested clinical review criteria and other clinical information to a health
care professional on the behalf of a patient.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(c)<span
style='mso-spacerun:yes'>  </span>A step therapy exception shall be granted to
a patient whose relevant medical condition is:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span><u>C</u></span><u>urrently stabilized by a
particular prescription drug prescribed by the patient's health care provider,
regardless of any current or prior insurance coverage, and the patient's health
care provider has prescribed continued treatment with the same prescription
drug; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Not currently stabilized by a
particular prescription drug and if any prescription drug required under the
applicable step therapy protocol: <o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Is contraindicated or will likely
cause an adverse reaction by or physical or mental harm to the patient;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Is expected to be ineffective based
on the known clinical characteristics of the patient and the known
characteristics of the prescription drug;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Has been previously prescribed to
the patient or is in the same pharmacologic class or has the same mechanism of
action as another prescription drug that has been prescribed to the patient and
was discontinued by the patient's health care provider due to lack of efficacy
or effectiveness, diminished effect, or an adverse event, regardless of any
current or prior insurance coverage of the prescription drug; or<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Will not serve the best interest of
the patient, based on medical necessity.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(d)<span
style='mso-spacerun:yes'>  </span>An insurer or utilization review organization
shall make a step therapy exception determination within seventy-two hours of
receipt of a request for an exception or filing of an appeal; provided that if
exigent circumstances exist, a determination shall be made within twenty-four
hours; provided further that if no determination has been made within the time
specified, the exception shall be deemed to be granted.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>If
a request for a step therapy exception is incomplete or additional clinically
relevant information is required, the insurer or utilization review
organization shall notify the prescribing practitioner within seventy-two hours
of submission of a request for an exception, or within twenty-four hours in
exigent circumstances, what additional or clinically relevant information is
required to approve or deny the step therapy exception request or appeal
pursuant to the criteria disclosed in subsection (a).<span
style='mso-spacerun:yes'>  </span>Once the requested information is submitted,
the applicable time period for an insurer or utilization review organization to
make a step therapy exception determination shall apply.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>Upon
the grant of a step therapy exception, the insurer or utilization review
organization shall authorize coverage for the particular prescription drug
prescribed by the patient's health care provider.<span
style='mso-spacerun:yes'>  </span>Any adverse determination under this
subsection shall be subject to appeal pursuant to the insurer or utilization
review organization's existing appeal procedures.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(e)<span
style='mso-spacerun:yes'>  </span>Every insurer or utilization review
organization subject to this section shall certify annually to the insurance
commissioner that the insurer or utilization review organization's step therapy
protocol meets the requirements of this section.<span
style='mso-spacerun:yes'>  </span>Any proposed change in protocol or clinical
review criteria shall be submitted to the insurance commissioner for approval
before it may be implemented by the insurer or utilization review organization.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(f)<span
style='mso-spacerun:yes'>  </span>Notwithstanding any law to the contrary, the
insurance division of the department of commerce and consumer affairs shall
adopt rules necessary for the purposes of this section. <o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(g)<span
style='mso-spacerun:yes'>  </span>Each insurer or utilization review
organization shall annually submit a report to the insurance division of the
department of commerce and consumer affairs, on forms prescribed by the
insurance division of the department of commerce and consumer affairs, that
includes the following:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The number of step therapy exception
requests received;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The type of health care providers or
the medical specialties of the health care providers submitting step therapy
exception requests;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The number of step therapy exception
requests that were:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Denied, including the reasons for
the denials;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Approved;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Initially denied and then appealed;
and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Initially denied and then
subsequently reversed by the internal appeals or external reviews; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(4)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The medical conditions under which
patients were granted step therapy exceptions due to the likelihood that
switching from the prescription drug will likely cause an adverse reaction by
or physical or mental harm to the insured.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(h)<span
style='mso-spacerun:yes'>  </span>This section applies to any state regulated
plan or health insurance coverage offered in connection with a state regulated
plan that provides coverage of a prescription drug pursuant to a policy that
meets the definition of a step therapy protocol, regardless of whether the
policy is described as a step therapy protocol.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(i)<span
style='mso-spacerun:yes'>  </span>Nothing in this section shall be construed to
prevent:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>An insurer or utilization review
organization from requiring a patient to try an AB-rated generic equivalent
drug or interchangeable biological product before providing coverage for a
name-brand prescription drug, unless the requirement meets the qualifications
for a step therapy exception pursuant to subsection (c);<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>An insurer or utilization review
organization from requiring a pharmacist to effect substitutions of
prescription drugs pursuant to section 328-92; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>A health care provider from
prescribing any prescription drug that the provider finds to be medically
appropriate for the patient.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(j)<span
style='mso-spacerun:yes'>  </span>For the purposes of this section:<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;AB-rated
generic equivalent drug&quot; means a prescription drug product that is
considered by the federal Food and Drug Administration to be therapeutically
equivalent to a particular name brand prescription drug.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Clinical
practice guidelines&quot; means a systematically developed statement to assist
decision-making by health care providers and patients about appropriate health
care for specific clinical circumstances and conditions.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Clinical
review criteria&quot; means the written screening procedures, decision
abstracts, clinical protocols, and practice guidelines used by an insurer or
utilization review organization to determine the medical necessity and appropriateness
of health care services.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Interchangeable
biological product&quot; has the same meaning as defined in section 328-91.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Medically
appropriate&quot; means health services and supplies that under the applicable
standard of care are appropriate:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>To improve or preserve health, life,
or function;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>To slow the deterioration of health,
life, or function; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>For the early screening, prevention,
evaluation, diagnosis, or treatment of a disease, condition, illness, or
injury.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Step
therapy exception determination&quot; means a determination as to whether a
step therapy protocol should apply in a particular situation or be overridden
in favor of immediate coverage of a health care provider's selected
prescription drug based on a review of the patient's or prescriber's request
for an exception and supporting rationale and documentation.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Step
therapy protocol&quot; means a protocol or program that requires the use of
specific prescription drugs in a specific sequence as a condition of coverage
under a policy.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Utilization
review organization&quot; means an entity that conducts utilization reviews,
other than an insurer that performs utilization reviews for its own policies.</u>&quot;</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
3.<span style='mso-spacerun:yes'>  </span>Chapter 432, Hawaii Revised Statutes,
is amended by adding a new section to article 1 to be appropriately designated
and to read as follows:</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><b>&quot;</b><b
style='mso-bidi-font-weight:normal'><u>§432:1-&nbsp;&nbsp;</u><span
style='mso-spacerun:yes'>  </span><u>Step therapy protocol; requirements;
exceptions.</u></b><span style='mso-spacerun:yes'>  </span><u>(a)<span
style='mso-spacerun:yes'>  </span>Clinical review criteria used to establish a
step therapy protocol shall be based on clinical practice guidelines.<span
style='mso-spacerun:yes'>  </span>Clinical practice guidelines shall:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Recommend that the prescription
drugs be taken in the specific sequence required by the step therapy protocol;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(2)</u><span
style='mso-tab-count:1'>  </span></span><u>Be developed and endorsed by a
multidisciplinary panel of experts that manages conflicts of interest among the
members of the writing and review groups by:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Requiring members to disclose any
potential conflict of interests with entities, including insurers, health
plans, and pharmaceutical manufacturers and recuse themselves of voting if they
have a conflict of interest;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Using a methodologist to work with
writing groups to provide objectivity in data analysis and ranking of evidence
through the preparation of evidence tables and facilitating consensus; and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Offering opportunities for public
review and comments;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-tab-count:2'>          </span><u>provided that in the absence of a
panel, peer reviewed publications shall suffice;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Be based on high quality studies,
research, and medical practices;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-tab-count:1'>     </span><u>(4)</u><span style='mso-tab-count:1'>  </span><u>Be
established under an explicit and transparent process that:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Minimizes biases and conflicts of
interest;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Explains the relationship between
treatment options and outcomes;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Rates the quality of the evidence
supporting recommendations; and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Considers relevant patient subgroups
and preferences;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(5)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Be continually updated through a
review of new evidence, research, and newly developed treatments; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(6)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Consider the needs of atypical
patient populations and diagnoses;<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><u>Nothing
in this subsection shall be construed to require a mutual benefit society,
utilization review organization, or health care provider to create any new
entity to develop clinical review criteria used for step therapy protocols.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(b)<span
style='mso-spacerun:yes'>  </span>When coverage of a prescription drug for the
treatment of any medical condition is restricted for use by a mutual benefit
society or utilization review organization through the use of a step therapy
protocol, the patient and the prescribing practitioner shall have access to request
a step therapy exception through a clear and convenient process which shall be readily
accessible through the mutual benefit society or utilization review
organization's website.<span style='mso-spacerun:yes'>  </span>A mutual benefit
society or utilization review organization may use its existing medical
exceptions or appeal process to satisfy this requirement; provided that the
process complies with the requirements of this section. <span
style='mso-spacerun:yes'> </span></u></span><span style='mso-bookmark:_Hlk114575812'><u><span
style='mso-bidi-font-family:"Courier New"'>A mutual benefit society or
utilization review organization shall upon written request:<o:p></o:p></span></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(1)</u><span
style='mso-tab-count:1'>  </span><u>Provide a</u></span><u>ll written clinical
review criteria relating to a particular condition or disease or a step therapy
exception determination;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(2)</u><span
style='mso-tab-count:1'>  </span><u>Display t</u></span><u>he requested
clinical review criteria and other clinical information on its website; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span><u>(3)</u><span
style='mso-tab-count:1'>  </span><u>D</u></span><u>istribute </u></span><span
style='mso-bookmark:_Hlk114575812'><u><span style='mso-bidi-font-family:"Courier New"'>t</span>he
requested clinical review criteria and other clinical information to a health
care professional on the behalf of a patient.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(c)<span
style='mso-spacerun:yes'>  </span>A step therapy exception shall be granted to
a patient whose relevant medical condition is:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span><u>C</u></span><u>urrently stabilized by a
particular prescription drug prescribed by the patient's health care provider,
regardless of any current or prior insurance coverage, and the patient's health
care provider has prescribed continued treatment with the same prescription
drug; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Not currently stabilized by a
particular prescription drug and if any prescription drug required under the
applicable step therapy protocol:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Is contraindicated or will likely
cause an adverse reaction by or physical or mental harm to the patient;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Is expected to be ineffective based
on the known clinical characteristics of the patient and the known
characteristics of the prescription drug;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Has been previously prescribed to
the patient or is in the same pharmacologic class or has the same mechanism of
action as another prescription drug that has been prescribed to the patient and
was discontinued by the patient's health care provider due to lack of efficacy
or effectiveness, diminished effect, or an adverse event, regardless of any
current or prior insurance coverage of the prescription drug; or<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Will not serve the best interest of
the patient, based on medical necessity.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(d)<span
style='mso-spacerun:yes'>  </span>A mutual benefit society or utilization
review organization shall make a step therapy exception determination within
seventy-two hours of receipt of a request for an exception or filing of an
appeal; provided that if exigent circumstances exist, a determination shall be
made within twenty-four hours; provided further that if no determination has
been made within the time specified, the exception shall be deemed to be
granted.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>If
a request for a step therapy exception is incomplete or additional clinically
relevant information is required, the mutual benefit society or utilization
review organization shall notify the prescribing practitioner within
seventy-two hours of submission of a request for an exception, or within twenty-four
hours in exigent circumstances, what additional or clinically relevant
information is required to approve or deny the step therapy exception request
or appeal pursuant to the criteria disclosed in subsection (a).<span
style='mso-spacerun:yes'>  </span>Once the requested information is submitted,
the applicable time period for a mutual benefit society or utilization review
organization to make a step therapy exception determination shall apply.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>Upon
the grant of a step therapy exception, the mutual benefit society or
utilization review organization shall authorize coverage for the particular
prescription drug prescribed by the patient's health care provider.<span
style='mso-spacerun:yes'>  </span>Any adverse determination under this
subsection shall be subject to appeal pursuant to the mutual benefit society or
utilization review organization's existing appeal procedures.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(e)<span
style='mso-spacerun:yes'>  </span>Every mutual benefit society or utilization
review organization subject to this section shall certify annually to the
insurance commissioner that the mutual benefit society or utilization review organization's
step therapy protocol meets the requirements of this section.<span
style='mso-spacerun:yes'>  </span>Any proposed change in protocol or clinical
review criteria shall be submitted to the insurance commissioner for approval
before it may be implemented by the mutual benefit society or utilization
review organization.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(f)<span
style='mso-spacerun:yes'>  </span>Notwithstanding any law to the contrary, the
insurance division of the department of commerce and consumer affairs shall
adopt rules necessary for the purposes of this section.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(g)<span
style='mso-spacerun:yes'>  </span>Each mutual benefit society or utilization
review organization shall annually submit a report to the insurance division of
the department of commerce and consumer affairs, on forms prescribed by the
insurance division of the department of commerce and consumer affairs, that
includes the following:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The number of step therapy exception
requests received;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The type of health care providers or
the medical specialties of the health care providers submitting step therapy
exception requests;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The number of step therapy exception
requests that were:<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(A)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Denied, including the reasons for
the denials;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(B)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Approved;<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(C)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Initially denied and then appealed;
and<o:p></o:p></u></span></p>

<p class=ASubparagraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:2'>          </span></span><u>(D)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>Initially denied and then
subsequently reversed by the internal appeals or external reviews; and<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(4)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>The medical conditions under which
patients were granted step therapy exceptions due to the likelihood that
switching from the prescription drug will likely cause an adverse reaction by
or physical or mental harm to the insured.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(h)<span
style='mso-spacerun:yes'>  </span>This section applies to any state regulated
plan or health insurance coverage offered in connection with a state regulated
plan that provides coverage of a prescription drug pursuant to a policy that
meets the definition of a step therapy protocol, regardless of whether the
policy is described as a step therapy protocol.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(i)<span
style='mso-spacerun:yes'>  </span>Nothing in this section shall be construed to
prevent:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>A mutual benefit society or
utilization review organization from requiring a patient to try an AB-rated
generic equivalent drug or interchangeable biological product before providing
coverage for a name-brand prescription drug, unless the requirement meets the
qualifications for a step therapy exception pursuant to subsection (c);<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>A mutual benefit society or
utilization review organization from requiring a pharmacist to effect
substitutions of prescription drugs pursuant to section 328-92; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>A health care provider from
prescribing any prescription drug that the provider finds to be medically
appropriate for the patient.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(j)<span
style='mso-spacerun:yes'>  </span>For the purposes of this section:<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;AB-rated
generic equivalent drug&quot; means a prescription drug product that is
considered by the federal Food and Drug Administration to be therapeutically
equivalent to a particular name brand prescription drug.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Clinical
practice guidelines&quot; means a systematically developed statement to assist
decision-making by health care providers and patients about appropriate health
care for specific clinical circumstances and conditions.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Clinical
review criteria&quot; means the written screening procedures, decision
abstracts, clinical protocols, and practice guidelines used by a mutual benefit
society or utilization review organization to determine the medical necessity
and appropriateness of health care services.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Interchangeable
biological product&quot; has the same meaning as defined in section 328-91.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Medically
appropriate&quot; means health services and supplies that under the applicable
standard of care are appropriate:<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(1)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>To improve or preserve health, life,
or function;<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(2)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>To slow the deterioration of health,
life, or function; or<o:p></o:p></u></span></p>

<p class=1Paragraph><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>(3)</u></span><span
style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:"Courier New"'><span
style='mso-tab-count:1'>  </span></span><u>For the early screening, prevention,
evaluation, diagnosis, or treatment of a disease, condition, illness, or
injury.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Step
therapy exception determination&quot; means a determination as to whether a
step therapy protocol should apply in a particular situation or be overridden
in favor of immediate coverage of a health care provider's selected
prescription drug based on a review of the patient's or prescriber's request
for an exception and supporting rationale and documentation.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Step
therapy protocol&quot; means a protocol or program that requires the use of
specific prescription drugs in a specific sequence as a condition of coverage
under a policy.<o:p></o:p></u></span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><u>&quot;Utilization
review organization&quot; means an entity that conducts utilization reviews,
other than a mutual benefit society that performs utilization reviews for its
own health benefit plans.</u>&quot;</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
</span><span style='mso-bookmark:_Hlk114575812'><span style='mso-bidi-font-family:
"Courier New"'>4</span>.<span style='mso-spacerun:yes'>  </span>Section
432D-23, Hawaii Revised Statutes, is amended to read as follows:</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span><b>&quot;</b><b
style='mso-bidi-font-weight:normal'>§432D-23<span style='mso-spacerun:yes'> 
</span>Required provisions and benefits. </b><span
style='mso-spacerun:yes'> </span>Notwithstanding any provision of law to the
contrary, each policy, contract, plan, or agreement issued in the State after
January 1, 1995, by health maintenance organizations pursuant to this chapter,
shall include benefits provided in sections 431:10-212, 431:10A-115,
431:10A-115.5, 431:10A-116, 431:10A-116.2, 431:10A-116.5, 431:10A-116.6,
431:10A-119, 431:10A-120, 431:10A-121, 431:10A-122, 431:10A-125, 431:10A-126,
431:10A-132, 431:10A-133, <u>431:10A-134,</u> 431:10A-140, [<s>and 431:10A-134,</s>]
<u>and 431:10A-&nbsp;&nbsp;&nbsp;</u> and chapter 431M.&quot;</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
5.<span style='mso-spacerun:yes'>  </span>This Act does not affect rights and
duties that matured, penalties that were incurred, and proceedings that were
begun before its effective date.</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
6.<span style='mso-spacerun:yes'>  </span>Statutory material to be repealed is bracketed
and stricken.<span style='mso-spacerun:yes'>  </span>New statutory material is
underscored.</span></p>

<p class=Effective><span style='mso-bookmark:_Hlk114575812'><span
style='mso-bidi-font-family:"Courier New"'><span style='mso-tab-count:1'>     </span></span>SECTION
7.<span style='mso-spacerun:yes'>  </span>This Act shall take effect upon its
approval, and shall apply to all health insurance and health benefit plans,
contracts, and agreements issued or renewed in this State after December 31,
2025.</span></p>

<p class=RegularParagraphs><span style='mso-bookmark:_Hlk114575812'><o:p>&nbsp;</o:p></span></p>

<span style='mso-bookmark:_Hlk114575812'></span>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=638
 style='border-collapse:collapse;mso-table-layout-alt:fixed;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid'>
  <td width=337 valign=top style='width:252.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right;mso-pagination:widow-orphan no-line-numbers'><span
  style='mso-bidi-font-family:"Courier New"'>INTRODUCED BY:<o:p></o:p></span></p>
  </td>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='mso-pagination:widow-orphan no-line-numbers'><span
  style='mso-bidi-font-family:"Courier New"'>_____________________________<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;mso-yfti-lastrow:yes;page-break-inside:avoid;
  height:44.55pt;mso-height-rule:exactly'>
  <td width=337 valign=top style='width:252.9pt;padding:0in 5.4pt 0in 5.4pt;
  height:44.55pt;mso-height-rule:exactly'>
  <p class=MsoNormal style='mso-pagination:widow-orphan no-line-numbers'><span
  style='mso-bidi-font-family:"Courier New"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=301 valign=top style='width:225.9pt;padding:0in 5.4pt 0in 5.4pt;
  height:44.55pt;mso-height-rule:exactly'>
  <p class=MsoNormal style='mso-pagination:widow-orphan no-line-numbers'><span
  style='mso-bidi-font-family:"Courier New"'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

</div>

<span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Courier New";
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman";
display:none;mso-hide:all;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'><br clear=all style='page-break-before:auto;
mso-break-type:section-break'>
</span>

<div class=WordSection3>

<p class=MsoNormal style='mso-pagination:widow-orphan no-line-numbers'><a
name="_Hlk114575683"><o:p>&nbsp;</o:p></a></p>

<span style='mso-bookmark:_Hlk114575683'></span><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Courier New";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New Roman";mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Courier New";
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br
clear=all style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal style='mso-pagination:widow-orphan no-line-numbers'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Report Title:<o:p></o:p></b></p>

<p class=ReportTitle><span style='mso-bidi-font-family:"Courier New"'>Health
Insurance; Prescription Drugs; Step Therapy Protocol; Clinical Review Criteria;
Clinical Practice Guidelines; Exceptions</span></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Description:<o:p></o:p></b></p>

<p class=Description><span style='mso-bidi-font-family:"Courier New"'>Establishes
requirements for the clinical review criteria and clinical practical guidelines
used to establish step therapy protocols.<span style='mso-spacerun:yes'> 
</span>Provides a process for a patient to request an exception to using step
therapy protocols.<span style='mso-spacerun:yes'>  </span>Establishes insurance
coverage requirements relating to the use of step therapy protocols and
standards to appeal an adverse step therapy exception determination.<o:p></o:p></span></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Arial",sans-serif'>The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.<o:p></o:p></span></i></p>

</div>

</body>

</html>
